Hello E , Hope all is well! I just wanted to make sure you received the email below about our early bird pricing ending tomorrow, Friday, August 12, for the Fierce Clinical Collective. This will be the last chance to save $400 on your registration. Click here to sign up today and take advantage of our best rates before it's too late! Please feel free to reach out to tharilall@questex.com with any questions or if interested in our special group discounts. We hope you can join us and look forward to meeting you in-person in Philadelphia on October 24-26. Best Regards, Aimee Gutzler Senior Event Director
Fierce Life Sciences |
|
|
From: Aimee Gutzler, Fierce Life Sciences Events <events@go.fiercelifesciences.com> Sent: Tuesday, August 9, 2022 3:30 pm To: newsletter@newslettercollector.com Subject: Optimize clinical quality and mitigate risk with access to the latest strategies. Rates increase this week, register NOW! |
|
|
Dear E, It has never been more important for clinical quality, compliance and operations professionals to have the tools and resources needed to effectively incorporate risk-based approaches within their operations. This knowledge is key for optimizing research, mitigating risk, ensuring patient safety, containing costs and more. Register now to join us for the Fierce Clinical Collective on October 24-26 in Philadelphia with access to Fierce Pharma's leading clinical events (together in one location!), including the Good Clinical Practice Summit and the Clinical Quality Oversight Forum. Be sure to take advantage of our Early Bird rates before it's too late! |
|
|
Over three powerhouse days, the Fierce Clinical Collective will feature top industry experts representing organizations such as AstraZeneca, Bristol-Myers Squibb, GSK, J&J, Merck, Pfizer, Takeda and more to lead in-depth discussions on all current challenges, concerns, best practices, trends, and experiences surrounding compliance and inspection readiness. Here are just a few examples why you and your team need to be here: |
|
|
GOOD CLINICAL PRACTICE SUMMIT |
|
|
Analyze the Evolving Landscape of GCP and the Impact on Quality Moderator: Dr. Kerstin Koenig, Vice President, Global Head Research & Development Quality, Bristol-Myers Squibb Panelists: Paul Houri, Head of BioResearch Quality Assurance, Johnson & Johnson Peter Alain, Vice President, Clinical Quality Assurance, Astellas Pharma, Inc. Eric Humes, Chief Quality Officer (CQO), Agenus How to Manage Quality in a Crisis? A Look at Business Continuity in Clinical Research Speaker: Karen Correa, PhD, Vice President, Head of Global Clinical Operations, Takeda |
|
|
CLINICAL QUALITY OVERSIGHT FORUM |
|
|
Implement Risk-Based Approaches and Inspection Readiness in Your Audit Strategies Moderator: Stephanie Haley, Director, Clinical Quality Assurance, Astellas Pharma US Panelists: Melissa Suprin, Head of Quality Risk Management, Pfizer Tashan Mistree, Head, Audit Conduct, GSK Kristel Van de Voorde, Vice President Global Quality and Regulatory Compliance GCP and PV, Bristol-Myers Squibb MyLe Hoang, Senior Director, Clinical Quality Assurance, Eisai Prioritize Oversight Activities with a Risk-Based Approach Resulting in a Continual Inspection-Ready State Moderator: Michael Walega, Head of Centralized Monitoring, Bristol-Myers Squibb Panelists: Klaus Goodwin, EQSM, LSS BB, Executive Director, Global R&D Quality & Compliance, Organon Sheri Kuss, Director, Clinical Quality Lead, Pfizer Scott Litrakis, Executive Director, Clinical Compliance & Risk Management, Bristol-Myers Squibb Maureen Cunningham, Senior Director, Clinical Oversight, Systems and Training, United Therapeutics Corporation |
|
|
ALSO FROM THE FIERCE CLINICAL COLLECTIVE... |
|
|
| | Decentralized Clinical Trials Summit - Discuss the established relationship between sponsors, CROs, and sites
- Understand how to recruit for a DCT and how this affects traditional clinical trial enrollment and informed consent
- Uncover the unique support a DCT study participant requires throughout the study
- Take a deep dive into real-world examples of decentralized clinical trials and how to derive meaningful data
|
|
|
IMPORTANT EVENT INFORMATION |
|
|
JOIN OUR SPEAKING FACULTY Please contact agutzler@questex.com as soon as possible if you are interested in speaking, as there are limited opportunities available. |
| |
|
PARTNER WITH US Position your company as a thought leader, promote your brand and engage with top clinical decision-makers. Complete the inquiry form here and a member of our team will follow up with you shortly! |
| |
|
BRING YOUR TEAM We offer special group rates when purchasing two or more registrations for any of the event options available within the Fierce Clinical Collective. Please contact us today to find out more! |
| |
|
BOOK YOUR HOTEL AND SAVE Discounted rates are available at the Hilton Philadelphia Penn's Landing for all Fierce Clinical Collective attendees. Learn more now. |
| |
|
Thank You to Our 2022 Clinical Collective Partners |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
Contact us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
|
.png "Fierce Clinical Collective")
.jpg "Fierce Clinical Collective - Speaking Opportunities")
